0.05Open0.05Pre Close23 Volume167 Open Interest2.50Strike Price115.00Turnover214.93%IV127.68%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier31DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1713Delta0.3593Gamma22.40Leverage Ratio-0.0029Theta0.0001Rho3.84Eff Leverage0.0008Vega
Cumberland Pharmaceuticals Stock Discussion
Cumberland Pharmaceuticals Receives FDA Orphan Drug and Rare Pediatric Disease Designations for New Treatment of Duchenne Muscular Dystrophy
$SNDL Inc (SNDL.US)$
$Cumberland Pharmaceuticals (CPIX.US)$
$Sonoma Pharmaceuticals (SNOA.US)$
$Ispire Technology (ISPR.US)$
$Veru Inc (VERU.US)$
$Greenlane (GNLN.US)$
$OrganiGram (OGI.US)$
$Cronos Group (CRON.US)$
$GrowGeneration (GRWG.US)$